AMY HULL: Open Payments
NPI 1710943063 · POTTSTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,178 in 59 payments from 23 companies in 2025. Trend: 2023 $1,143 · 2024 $1,117 · 2025 $1,178
Food & beverage: $1,178
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $210 |
| PFIZER INC. | 7 | $160 |
| GlaxoSmithKline, LLC. | 8 | $148 |
| Lilly USA, LLC | 5 | $103 |
| Novo Nordisk Inc | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Amgen Inc. | 2 | $33 |
| Medtronic, Inc. | 1 | $28 |
Products named: TRELEGY ELLIPTA, JARDIANCE, SYNTHROID, UBRELVY, VRAYLAR, PREVNAR 20, ELIQUIS, AIRSUPRA.
Industry payments across PA — which companies pay providers there.
